There Is a Close Association between the Recovery of Liver Injury and Glycemic Control after SGLT2 Inhibitor Treatment in Japanese Subjects with Type 2 Diabetes: A Retrospective Clinical Study
Tomoe Kinoshita
Masashi Shimoda
Junpei Sanada
Yoshiro Fushimi
Yurie Hirata
Shintaro Irie
Atsushi Obata
Tomohiko Kimura
Hidenori Hirukawa
Kenji Kohara
Fuminori Tatsumi
Shinji Kamei
Shuhei Nakanishi
Tomoatsu Mune
Kohei Kaku
Hideaki Kaneto
10.6084/m9.figshare.6270008.v1
https://adisjournals.figshare.com/articles/figure/There_Is_a_Close_Association_between_the_Recovery_of_Liver_Injury_and_Glycemic_Control_after_SGLT2_Inhibitor_Treatment_in_Japanese_Subjects_with_Type_2_Diabetes_A_Retrospective_Clinical_Study/6270008
<p></p><p><strong>Article full
text</strong></p>
<p><br>
The full text of this article can be found <a href="https://link.springer.com/article/10.1007/s13300-018-0447-8"><b>here</b>.</a><br>
<br>
<strong>Provide enhanced digital features for this article</strong><br>
If you are an author of this publication and would like to provide additional
enhanced digital features for your article then please contact <u>adisrapidplus@springer.com</u>.<br>
<br>
The journal offers a range of additional features designed to increase
visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the
highest scientific standard and all features are marked as ‘peer reviewed’ to
ensure readers are aware that the content has been reviewed to the same level
as the articles they are being presented alongside. Moreover, all sponsorship
and disclosure information is included to provide complete transparency and
adherence to good publication practices. This ensures that however the content
is reached the reader has a full understanding of its origin. No fees are
charged for hosting additional open access content.<br>
<br>
Other enhanced features include, but are
not limited to:<br>
• Slide decks<br>
• Videos and animations<br>
• Audio abstracts<br>
• Audio slides<u></u></p><br><p></p>
2018-06-18 15:45:57
Liver injury
SGLT2 inhibitor
Type 2 diabetes mellitus